~~<i id='6F748045CC'><strike id='6F748045CC'><tt id='6F748045CC'><pre id='6F748045CC'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：leisure time 2025-09-30 15:55:06 Page View：1

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Methadone treatment changes are coming. Do they go far enough?
Next article： Trump demands the U.S. pay no more for drugs than other countries … again

Wikipedia

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Physicians and social media: If you see something, say something?

AfterJoannaGaines,co-hostofHGTV's"FixerUpper,"shownherewithherhusband,Chip,postedanultrasoundofherba

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

ThisundatedphotoprovidedbytheEllenTroutZooshowsgiraffeTwigaatthezooinLufkin,Texas.Twiga,whowasfoundd